3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other
1
Conditions
Polycystic Ovary Syndrome
1
Overweight
1
Obesity
1
Insulin Resistance
1
Hyperandrogenism
1
Interventions
Metformin
14
Clomiphene
6
Progesterone
5
Chorionic Gonadotropin
5
drospirenone and ethinyl estradiol combination
4
Sugars
4
Letrozole
4
Flutamide
4
Estrogens
4
Cholecalciferol
4
follitropin alfa
3
Pioglitazone
3
Medroxyprogesterone Acetate
3
Glycoprotein Hormones, alpha Subunit
3
Estradiol
3
Vitamin D
2
Testosterone
2
Resistance Training
2
Raloxifene Hydrochloride
2
Ovidrel
2
Liraglutide
2
Leuprolide
2
Glucose Tolerance Test
2
Exenatide
2
Ethinyl Estradiol
2
Contraceptives, Oral
2
Continuous Positive Airway Pressure
2
saxagliptin
1
salicylsalicylic acid
1
penclomedine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Polycystic Ovary Syndrome
×
licogliflozin
×
Clear all
NCT03152591
2021-01-05
PCOS
Novartis
Phase 2
Completed
29 enrolled
24 charts